Exosome Isolation for Proteomic Analyses and RNA Profiling
Purchase on Springer.com
$49.95 / €39.95 / £34.95*
* Final gross prices may vary according to local VAT.
While the existence of exosomes has been known for over three decades, they have garnered recent interest due to their potential diagnostic and therapeutic relevance. The expression and release of specific tumor-derived proteins into the peripheral circulation has served as the centerpiece of cancer screening and diagnosis. Recently, tissue-associated microRNA (miRNA) has been shown to be characteristic of tumor type and developmental origin, as well as exhibit diagnostic potential. Tumors actively release exosomes, exhibiting proteins and RNAs derived from the originating cell, into the peripheral circulation and other biologic fluids. Recently, we have demonstrated the presence of miRNAs within the RNA fraction of circulating tumor-derived exosomes. Currently, in over 75 investigations compiled in ExoCarta, over 2,300 proteins and 270 miRNAs have been linked with exosomes derived from biologic fluids. Our previous work has indicated that these circulating exosomal proteins and miRNAs can serve as surrogates for the tumor cell-associated counterparts, extending their diagnostic potential to asymptomatic individuals. In this chapter, we compare currently utilized methods for purifying exosomes for postisolation analyses. The exosomes derived from these approaches were assessed for quantity and quality of specific RNA populations and specific marker proteins. These results suggest that, while each method purifies exosomal material, circulating exosomes isolated by ExoQuick precipitation produces exosomal RNA and protein with greater purity and quantity than chromatography, ultracentrifugation, and DynaBeads. While this precipitation approach isolates exosomes in general and does not exhibit specificity for the originating cell, the increased quantity and quality of exosomal proteins and RNA should enhance the sensitivity and accuracy of down-stream analyses, such as qRT-PCR profiling of miRNA and mass spectrometric and electrophoretic analyses of exosomal proteins.
- Taylor DD, Doellgast GJ. (1979) Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography. Anal Biochem 98, 53–59. CrossRef
- Simpson RJ, Jensen SS, Lim JWE. (2008) Proteomic profiling of exosomes: Current perspectives. Proteomics 8, 4083–4099. CrossRef
- Taylor DD, Homesley HD, Doellgast GJ. (1980) Binding of specific peroxidise-labeled antibody to placental-type alkaline phosphatase on tumor-derived membrane fragments. Cancer Res 40, 4964–4969.
- Raposo G, Tenza D, Mecheri S, et al. (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8, 2631–2645.
- Heijnen HFG, Schiel AE, Fijnheer R, et al. (1999) Activation platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha granules. Blood 94, 3791–3799.
- Taylor DD, Black PH. (1986) Shedding of plasma membrane fragments: Neoplastic and developmental importance. In: Developmental Biology, (M. Steinberg, ed.) 3, 33–57.
- Taylor DD, Bohler HC, Gercel-Taylor C. (2006) Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss. Mol Immunol, 43, 1872–1880. CrossRef
- Pan BT, Johnstone RM. (1983) Fate of the transferring receptor during maturation of the sheep reticulocytes in vitro: Selective externalization of the receptor. Cell 33, 967–978. CrossRef
- Skog J, Wurdinger T, van Rijn S, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biol 10, 1470–1476. CrossRef
- Taylor DD, Gercel-Taylor C. (2005) Tumour-derived exosomes as mediates of T-cell signaling defects. Brit J Cancer 92, 305–311.
- Mathivanan S, Simpson RJ. (2009) ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997–5000. CrossRef
- Taylor DD, Gercel-Taylor C. (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110, 13–21. CrossRef
- Laemmli U K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685. CrossRef
- Brown, R., Clugston, C., Burns, P., et al. (1993) Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 55, 678–684. CrossRef
- Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G, Altevogt P. (2007) Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 107, 563–571. CrossRef
- Fernández-Llama P, Khositseth S, Gonzales PA, Star RA, Pisitkun T, Knepper MA. (2010) Tamm-Horsfall protein and urinary exosome isolation. Kidney Int 77, 736–742. CrossRef
- Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, Carter BS, Breakefield XO, Toner M, Irimia D. (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10, 505–511. CrossRef
- Admyre C, Johansson SM, Qazi KR, Filén JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S. (2007) Exosomes with immune modulatory features are present in human breast milk. J Immunol 179, 1969–1978.
- Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT. (2010) Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One 5, e8577. CrossRef
- Exosome Isolation for Proteomic Analyses and RNA Profiling
- Book Title
- Serum/Plasma Proteomics
- Book Subtitle
- Methods and Protocols
- pp 235-246
- Print ISBN
- Online ISBN
- Series Title
- Methods in Molecular Biology
- Series Volume
- Series Subtitle
- Methods and Protocols
- Series ISSN
- Humana Press
- Copyright Holder
- Springer Science+Business Media, LLC
- Additional Links
- Editor Affiliations
- ID1. Ludwig Inst. for Cancer Research, Joint Proteomics Laboratory (JPSL), Royal Melbourne Hospital
- ID2. Ludwig Inst. for Cancer Research, Joint Proteomics Laboratory, Royal Melbourne Hospital
- Author Affiliations
- 1. James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA
To view the rest of this content please follow the download PDF link above.